Melphalan: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Melphalan. Educational only — not medical advice.
Labeled uses
HEPZATO for injection, as a component of the HEPZATO KIT, is indicated as a liver-directed treatment for adult patients with uveal melanoma with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease or extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection or radiation.
Source: FDA labeling via NIH DailyMed (set 4f83c8f7…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.